Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
866
Sort by:
Asia-Pacific Vaccine Market - 2023-2031
US$ 2,999.00
The Asia-Pacific Vaccine Market was valued at US$ 12.33 billion in 2023 and is anticipated to reach US$ 17.82 billion by 2031, at a CAGR of 0.061 from 2026 to 2032. The report delivers in-depth insigh...
January 2026
218 pages
Travel Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Composition (Mono Vaccines v/s Combination Vaccines), By Disease Indication (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others), By Travel Type (Domestic v/s International) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Travel Vaccine Market is projected to expand from USD 6.81 Billion in 2025 to USD 11.56 Billion by 2031, achieving a CAGR of 9.22%. Travel vaccines are biological preparations designed to p...
January 2026
182 pages
Malaria Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vaccine Type (Pre-Erythrocytic, Erythrocytic, Multi-antigen, Others), By Route of Administration (Intramuscular, Subcutaneous, Intradermal, Others), By Region and Competition 2021-2031F
US$ 4,500.00
The Global Malaria Vaccine Market is projected to experience substantial growth, increasing from USD 1.41 Billion in 2025 to USD 3.84 Billion by 2031, achieving a CAGR of 18.17%. This sector focuses o...
January 2026
185 pages
Smallpox Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Antiviral Drugs, Vaccination, Supportive Care), By Product Type (Vaccines, Antiviral Drugs), By End user (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Smallpox Treatment Market is projected to expand from USD 75.12 Million in 2025 to USD 94.61 Million by 2031, achieving a compound annual growth rate of 3.92%. This market encompasses medic...
January 2026
180 pages
Conjugate Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccine), By Disease Indication (Pneumococcal, Influenza, Meningococcal, Typhoid), By End-User (Hospitals & Clinics, Ambulatory care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Conjugate Vaccine Market is projected to expand from USD 19.69 Billion in 2025 to USD 34.05 Billion by 2031, reflecting a compound annual growth rate of 9.56%. These vaccines are created by...
January 2026
182 pages
Allergy Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Allergy Type (Allergic Asthma, Cat Dander Allergy, Grass Pollen Hypersensitivity, Peanut Hypersensitivity, Seasonal Allergic Rhinitis, Tree Pollen Hypersensitivity), By Vaccine Type (Cat Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine, Peanut Allergy Vaccine, Ragweed Allergy Immunotherapy Vaccine), By Application (HIV, Oncology, Respiratory), By End User (Homecare, Hospitals, Specialty Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Allergy Vaccine Market is projected to expand from USD 1.42 Billion in 2025 to USD 2.29 Billion by 2031, reflecting a CAGR of 8.29%. These vaccines, technically known as allergen immunother...
January 2026
180 pages
Respiratory Disease Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Others), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others), By Region & Competition,, 2021-2031F
US$ 4,500.00
The Global Respiratory Disease Vaccine Market is projected to expand from a valuation of USD 95.69 Billion in 2025 to USD 102.49 Billion by 2031, reflecting a compound annual growth rate of 1.15%. The...
January 2026
185 pages
Meningococcal Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Conjugate, Polysaccharide, Combination, Others), By Age Group (Infant, Children & Adult), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Meningococcal Vaccines Market is projected to expand from USD 4.38 Billion in 2025 to USD 6.18 Billion by 2031, reflecting a compound annual growth rate of 5.91%. These biological preparati...
January 2026
186 pages
Asia Pacific Vaccines Market Size and Forecast (2021 - 2031)
US$ 3,450.00
The Asia Pacific Vaccines Market is projected to grow significantly, reaching approximately US$ 22,940.5 million by 2031, up from US$ 15,065.1 million in 2024, with an estimated compound annual growth...
January 2026
207 pages
Europe Vaccines Market Size and Forecast (2021 - 2031)
US$ 3,450.00
The Europe Vaccines Market is projected to grow significantly, reaching approximately US$ 35,815.1 million by 2031, up from US$ 24,528.3 million in 2024, with an estimated compound annual growth rate...
January 2026
208 pages
BCG Vaccine Market 2026
US$ 2,999.00
The BCG Vaccine Market was valued at in and is anticipated to reach by , at a CAGR of 0.048 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth...
January 2026
220 pages
Vaccine Adjuvants Market Size, Share & Trends Analysis Report By Type (Pathogen, Adjuvant Emulsion, Particulate), By Application (Infectious Disease, Cancer), By Administration (Oral, Intradermal, Intranasal), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
... vaccine adjuvants market is expected to reach USD 758.8 million by 2025, according to a new report by Grand View Research, Inc. The significance of adjuvant research in the development of vaccines ... for vaccine adjuvants. Furthermore, rising prevalence of cervical cancer is anticipated to boost the market. ...
January 2026
120 pages
Hepatitis B Vaccine Market - 2022
US$ 2,999.00
The Hepatitis B Vaccine Market was valued at USD 4.3 billion in 2022 and is anticipated to reach by , at a CAGR of 0.046 from 2026 to 2032. The report delivers in-depth insights into key market dynami...
January 2026
217 pages
COVID-19 Vaccine Market - 2024-2033
US$ 2,999.00
The COVID-19 Vaccine Market was valued at US$ 13.43 billion in 2024 and is anticipated to reach US$ 29.98 billion by 2033, at a CAGR of 0.098 from 2026 to 2032. The report delivers in-depth insights i...
January 2026
200 pages
The 2027-2032 World Outlook for Human Vaccines
US$ 1,195.00
This study covers the world outlook for human vaccines across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for human vaccines. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country ...
January 2026
287 pages
The 2027-2032 World Outlook for Influenza a (H1N1) Vaccines
US$ 1,195.00
... study covers the world outlook for Influenza A (H1N1) vaccines across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for Influenza A (H1N1) vaccines. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Influenza Vaccines
US$ 1,195.00
This study covers the world outlook for influenza vaccines across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for influenza vaccines. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
288 pages
The 2027-2032 World Outlook for Pediatric Vaccines
US$ 1,195.00
This study covers the world outlook for pediatric vaccines across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for pediatric vaccines. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
288 pages
The 2027-2032 World Outlook for Prophylactic Vaccines
US$ 1,195.00
This study covers the world outlook for prophylactic vaccines across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for prophylactic vaccines. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Veterinary Vaccines
US$ 1,195.00
This study covers the world outlook for veterinary vaccines across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for veterinary vaccines. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
Global Avian Influenza Vaccines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... manufacturers of Avian Influenza Vaccines, with price, sales, revenue and global market share of Avian Influenza Vaccines in 2017 and 2018. Chapter 3, the Avian Influenza Vaccines competitive situation, sales, revenue and global market share ...
January 2026
152 pages
The 2027-2032 World Outlook for Adult and Adolescent Pneumococcal Vaccines
US$ 1,195.00
This study covers the world outlook for adult and adolescent pneumococcal vaccines across more than 190 countries. For each year ... demand, or the P.I.E., for adult and adolescent pneumococcal vaccines. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...
January 2026
293 pages
The 2027-2032 World Outlook for Adult and Adolescent Vaccines
US$ 1,195.00
... study covers the world outlook for adult and adolescent vaccines across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... P.I.E., for adult and adolescent vaccines. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
288 pages
The 2027-2032 World Outlook for Cancer Vaccines
US$ 1,195.00
This study covers the world outlook for cancer vaccines across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for cancer vaccines. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country ...
January 2026
287 pages
The 2027-2032 World Outlook for DNA Vaccines
US$ 1,195.00
This study covers the world outlook for DNA vaccines across more than 190 ... does not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for DNA vaccines. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country ...
January 2026
287 pages
